We recently published an article titled Why These 10 Stocks Soared Today . In this article, we are going to take a look at where Hims & Hers Health, Inc. (NYSE:HIMS) stands against the other stocks that soared on Tuesday.
The stock market finished Tuesday’s trading on a positive note with all major indices ending in the green, buoyed by the influx of corporate earnings results.
The Dow Jones grew by 0.75 percent, the S&P 500 rose by 0.58 percent, and the Nasdaq was up by 0.55 percent.
Ten companies mirrored the broader market optimism, leading the charge with strong gains, predominantly driven by impressive earnings results.
To come up with the list, we considered only the stocks with a $2-billion market capitalization and $5-million trading volume.
A nurse in a telehealth platform talking with a patient on video call for consultation.
Hims & Hers Health, Inc. (NYSE:HIMS)
Hims & Hers Health, Inc. (NYSE:HIMS) soared by 23.03 percent on Tuesday to end at $35.04 apiece as investors cheered news that it partnered with Novo Nordisk for a long-term collaboration to market blockbuster weight loss medicine Wegovy.
In a statement, Hims & Hers Health, Inc. (NYSE:HIMS) said that Americans can now access NovoCare Pharmacy directly through the Hims & Hers platform, with a bundled offering of all dose strengths of Wegovy and a Hims & Hers membership, which includes access to 24/7 care, ongoing clinical support, and nutrition guidance, all in one place.
The companies are also working on the development of a roadmap that combines Novo Nordisk’s innovative treatments with Hims & Hers Health, Inc.’s (NYSE:HIMS) ability to scale access to quality care, aiming to improve long-term outcomes for more people, more affordably.
It can be learned that HIMS has been making a compounded knock-off version of the treatment that helped propel its sales over the past few years, but was later discontinued after the Food and Drug Administration announced that the treatment was already back in sufficient supply.
Overall HIMS ranks 1st on our list of the stocks that soared on Tuesday. While we acknowledge the potential of HIMS as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. There is an AI stock that went up since the beginning of 2025, while popular AI stocks lost around 25%. If you are looking for an AI stock that is more promising than HIMS but that trades at less than 5 times its earnings, check out our report about this cheapest AI stock .
READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires .
Disclosure: None. This article is originally published at Insider Monkey .